Twitter (TWTR) working with Goldman Sachs on sale - FT
- Wall St. gains across sectors ahead of Trump inauguration
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Herbalife (HLF) Says SEC Requested Documents on Anti-Corruption Compliance in China; Reviewed with DoJ
- Investment Focus: History suggests Trump month will be stocks down, dollar up
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Twitter (NYSE: TWTR) working with Goldman Sachs on sale, the FT reports.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pacific Crest Resumes Twitter, Inc. (TWTR) at Sector Weight
- Rite Aid (RAD) Could See 'Massive Downside' if Walgreens' (WBA) Deal Fails - Evercore ISI
- Ethicon Announces Acquisition of Megadyne Medical Products (JNJ)
Create E-mail Alert Related CategoriesMergers and Acquisitions, Rumors
Related EntitiesGoldman Sachs, Twitter
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!